While diarrheal illnesses are extremely common in communities and hospitals throughout the world, an etiologic diagnosis may be expensive and cost-ineffective. Although the presence of fecal leukocytes are helpful in the diagnosis and specific therapy of inflammatory diarrheas, this requires prompt microscopic examination of fecal specimens (preferably obtained in a cup rather than a swab or diaper) by a trained observer. We developed a simple, sensitive test for the detection of leukocytes in fecal specimens using antilactoferrin antibody. Whereas radial immunodiffusion detected 0.02 ,ug of lactoferrin (LF) 
While diarrheal illnesses are extremely common in communities and hospitals throughout the world, an etiologic diagnosis may be expensive and cost-ineffective. Although the presence of fecal leukocytes are helpful in the diagnosis and specific therapy of inflammatory diarrheas, this requires prompt microscopic examination of fecal specimens (preferably obtained in a cup rather than a swab or diaper) by a trained observer. We developed a simple, sensitive test for the detection of leukocytes in fecal specimens using antilactoferrin antibody. Whereas radial immunodiffusion detected 0.02 ,ug of lactoferrin (LF) per ,ul or .2,000 leukocytes per ,ul, latex agglutination (LA) readily detected .0.001 ,ig of LF per ,ul or .200 leukocytes per ,ul added to stool specimens. Despite the destruction or loss of morphologic leukocytes on storage for 1 to 7 days at 4°C or placement of specimens on swabs, measurable LF remained stable. Initial studies of stool specimens from six patients with Salmonella or Clostridium difficile enteritis were positive and those from three controls were negative for LF by LA. Of 17 children in Brazil with inflammatory diarrhea (.1 leukocyte per high-power field), 16 (94%) had LF titers of >1:50 by LA, whereas only 3 of 12 fecal specimens with <1 leukocyte per high-power field on methylene blue examination and none of 7 normal control specimens had an LF titer of >1:50 by LA. Of 16 fecal specimens from patients with C. difficile diarrhea (cytotoxin titers, .1:1,000), 95% (n = 15) had detectable LF by LA (in titers of 1:100 to 1:800). Finally, of 48 fecal specimens from healthy adult U.S. volunteers before and after experimental shigellosis and of 29 fecal specimens from children with documented shigellosis and hospitalized controls in northeastern Brazil, fecal LF titers ranged from 1:200 to >1:5,000 in 96% (25 of 26) samples from patients with shigellosis (and reported positive for fecal leukocytes), while 51 controls consistently had fecal LF titers of <1:200. We conclude that fecal LF is a useful marker for fecal leukocytes, even when they are morphologically lost on swab specimens or when they are destroyed on transport or storage or by cytotoxic fecal specimens.
Diarrheal illnesses are extremely common throughout the world, causing 2 to 16 or more illnesses per person per year in developed and developing countries (7, 15) and often posing diagnostic and therapeutic questions for physicians. The causes of diarrhea include a wide variety of etiologic agents, many of which have been recognized only in the past two decades (7) . However, these agents do not need to be exhaustively sought in every instance of this common problem (6, 23) , and the cost of indiscriminate use of etiologic studies for diagnosis is prohibitive. The cost for each positive routine stool culture result has exceeded $900 to $1,000 (8, 11) .
An important diagnostic clue in considering whether diarrhea is a noninflammatory or an inflammatory process is the examination for fecal leukocytes (4, 9, 12 from a fecal specimen in a cup. The specimen is stained so that leukocytes are clearly distinguishable in the fecal debris. This requires the immediate availability of a skilled person with a microscope to stain and examine fresh fecal specimens in the clinic or emergency areas where the patient is seen. It may also be difficult to obtain fecal specimens in a cup (these specimens are superior to swab or diaper specimens for examination of fecal leukocytes; swab or diaper specimens are only 44% sensitive, whereas cup specimens are 95% sensitive for fecal leukocyte detection by methylene blue examination of specimens from patients with culturedocumented shigellosis [12] ). Therefore, a method that remains sensitive when swabs are used and that remains sensitive when specimens are transported or stored (overnight) would be helpful and might allow a wider application of a selective diagnostic and treatment algorithm.
We developed a simple in vitro test for a leukocyte marker that is highly sensitive to the numbers of fecal leukocytes typically found in inflammatory diarrheal specimens and that can be quickly and easily done either in the clinic or later (after transportation or storage) in the laboratory. Only a minimum amount of training is required to learn how to perform the test.
We initially explored the leukocyte marker leukocyte esterase (an enzyme used in detecting leukocytes in the urine) (16) and found that, in contrast to its usefulness in testing leukocytes in urine, normal fecal specimens gave a positive result, so we abandoned further studies with leukocyte esterase. Instead we found that lactoferrin, an ironbinding glycoprotein found concentrated in secondary gran-ules in leukocytes (10, 19) For a negative control, latex beads were prepared as described above, but rabbit anti-human lactoferrin was not added. The assay has been licensed and is being developed as a commercial product by Techlab Inc., Blacksburg, Va. (a patent is pending).
Isolation of neutrophils. Neutrophils were obtained from normal heparinized (10 ml) venous blood by a one-step Ficoll-Hypaque separation procedure (Neutrophil Isolation Medium; Los Alamos Diagnostics, Los Alamos, N.M.) (3). The polymorphonuclear leukocytes (PMNs) were washed three times with Hanks balanced salt solution (HBSS). Residual erythrocytes were lysed by hypotonic lysis with 3 ml of iced 0.22% sodium chloride solution for 45 s and then with 0.88 ml of 3% sodium chloride solution, this was followed by the addition of 5 ml of HBSS and centrifugation. A 1:2 suspension of PMNs in diluted stool was prepared by using normal stool of mixed with 1 ml of HBSS to make a cloudy suspension and adding 0.5 ml of previously counted PMNs to 0.5 ml of the stool suspension. A 1:2 suspension of PMNs in HBSS was prepared as a control for comparison with fecal suspensions.
To standardize our antibody-coated latex bead preparation, we determined dose-response curves using a solution of lactoferrin (L-0520; Sigma) diluted in HBSS.
Testing urate a rayon-tipped swab (Culturette II collection and transport system; Marion Scientific, Kansas City, Mo.). The swab was then placed in 390 ,u of HBSS and shaken, and the excess fluid was squeezed out to make a calculated 1:4 dilution that we could examine for leukocytes directly and by the lactoferrin assay.
PMNs were quantified morphologically at time zero and at subsequent intervals by using a ruled Neubauer-type hemacytometer chamber. To aid in visualizing the nuclei, methylene blue stain was incorporated into the counting solutions (20 ,u of solution, 20 ptl of methylene blue, 160 ,ul of HBSS).
RESULTS
Sensitivity of lactoferrin latex agglutination assay for lactoferrin. As shown in Fig. 1 , the lactoferrin latex agglutination assay done with three different antibody-coated bead preparations was sensitive to less than 1 ng of purified lactoferrin per ,ul, with readily apparent agglutination of the latex beads.
The lowest concentration of lactoferrin that consistently gave 1+ or greater agglutination was 0.31 ng/,u, a concentration that, from previously published data (10) after storage in a refrigerator or on swabs, the number of PMNs in the suspensions were counted and then the PMNs were placed in 1% Triton X-100 or in a cloudy suspension of normal stool or both. Then, we reexamined the suspension for PMN counts by microscopy and lactoferrin titer by the latex agglutination assay immediately and after storage in a refrigerator or on swabs for 1 to 6 days ( Fig. 3 and 4) . In contrast to the lability of PMN numbers and morphologies seen after refrigeration, lactoferrin titers were remarkably stable even when the stool or Triton X-100 suspensions were refrigerated for several days.
There was a striking loss of PMN numbers after PMNs were placed on swab specimens (Fig. 4) 4) enteritis were positive and three control stool specimens were negative for lactoferrin by latex agglutination, thus demonstrating the feasibility of using this test to examine patient fecal specimens. In preliminary studies to test whether the lactoferrin latex agglutination method correlated with evidence of fecal leukocytes on microscopy of methylene blue-stained specimens in a field setting, fecal specimens in cups from 29 children with acute diarrhea presenting to a Rehydration Center in Fortaleza, Ceara, Brazil, where stool cultures are not routinely available, were promptly examined. Of 17 children whose specimens had one or more leukocytes per high-power field on microscopic examination, we determined by latex agglutination that 16 (94%) had fecal lactoferrin at a titer of greater than or equal to 1:50. In only 3 of 12 children (25%) whose specimens had less than one leukocyte per high-power field was lactoferrin present at a titer of greater than or equal to 1:50. In addition, none of the seven normal control specimens from healthy individuals without diarrhea in Charlottesville, Va., was positive for lactoferrin at a titer of greater than or equal to 1:50. When we systematically examined by cell culture assay 16 fecal specimens from patients with nosocomial diarrhea at the University of Virginia Hospital that had C. difficile cytotoxin titers greater than or equal to 1:1,000, we found by latex agglutination that 95% (15 specimens) had lactoferrin titers that ranged from 1:100 to 1:800, even though PMNs were not seen in 6 of 9 of these specimens that were promptly examined after methylene blue staining. Of 14 fecal specimens with cytotoxin titers of 1:10 to 1:100, 9 (64%) had moderate lactoferrin titers (1:100 to 1:400), while only 1 of 16 specimens (6%) with no detectable cytotoxin had a lactoferrin titer of >1:50 (1:100).
Finally, we tested fecal specimens from patients with culture-documented shigellosis from the University of Maryland Center for Vaccine Development and Hospital das Clinicas in Fortaleza, Ceara, Brazil (Fig. 5) . and pediatric patients with documented shigellosis with fecal leukocytes on examination by methylene blue staining, fecal lactoferrin titers were 21:200 (ranging to 21:5,000).
DISCUSSION
Results of the studies described here demonstrate the practical feasibility of using latex agglutination for determination of fecal lactoferrin as a simple, semiquantitative marker for PMNs in fecal specimens. Lactoferrin latex agglutination provided a highly sensitive means to quantify PMNs in fecal specimens. It detected lactoferrin at < 1 ng/,ul and <200 PMNs per ,ul, a number far less that the expected number of PMNs in inflammatory fecal specimens. Although fecal (21) noted that 99% of 304 stool specimens from patients infected with Shigella species, 96% of 262 stool specimens from patients infected with C jejuni, and 98% of 137 stool specimens from patients with Entamoeba histolytica showed >1 leukocyte per high-power field, 20 to 29% of patients with rotaviral, enterotoxigenic E. coli, and cholera (all presumably noninflammatory diarrhea) had 11 to 20 leukocytes per high-power field, suggesting that the threshold separating patients with primary inflammatory diarrhea from those with noninflammatory diarrhea may be higher in areas where multiple bacterial and parasitic infections are common. Harris et al. (9) In conclusion, fecal lactoferrin can readily be detected by a simple latex agglutination assay and provides a useful marker for inflammatory diarrhea, even when fecal leukocytes are destroyed by transportation, storage, swab, or toxins. The ultimate utility of this assay in clinical or field settings and its potential application to specimens other than stool specimens require prospective clinical studies in different field, hospital, clinical, and laboratory settings.
